Literature Review: Moving the Druggable Needle
The Use of an mRNA Display Technology and Affinity-Based Selection Is Used to Find Inhibitors to an Enzyme of Interest
To Surge or Not to Surge?
Experts Discuss Inclusion of a Surge Tank in an End-to-End Continuous Biomanufacturing Train
New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
- Swift Biosciences
- 58 Parkland Plaza
- Suite 100
- Ann Arbor MI, 48103
- UNITED STATES
Swift Biosciences makes products that detect genes and gene products and also helps users analyze samples. Swift Biosciences opened its doors in February 2010 and launched the first retail product in its myT™ Primers platform—myT™ BRAF—for detection of BRAF mutations in February of 2012.